143 related articles for article (PubMed ID: 36249049)
1. Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension.
Huang PW; Lin CY; Lee LY; Hsieh CH; Hsu CL; Liau CT; Fan KH; Huang SF; Liao CT; Chang TC; Wang HM
Front Oncol; 2022; 12():866890. PubMed ID: 36249049
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
3. A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.
Huang PW; Lin CY; Hsieh CH; Hsu CL; Fan KH; Huang SF; Liao CT; Ng SK; Yen TC; Chang JT; Wang HM
Biomed J; 2018 Apr; 41(2):129-136. PubMed ID: 29866601
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant therapy for patients with loco-regionally advanced oral squamous cell carcinoma who are at high risk of recurrence.
Yanamoto S; Denda Y; Ota Y; Hasegawa T; Akashi M; Okura M; Yamada SI; Kurita H; Yamakawa N; Kirita T; Ueda M; Umeda M;
Int J Oral Maxillofac Surg; 2020 Jul; 49(7):848-853. PubMed ID: 31926824
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Ohtsu A; Shimada Y; Shirao K; Boku N; Hyodo I; Saito H; Yamamichi N; Miyata Y; Ikeda N; Yamamoto S; Fukuda H; Yoshida S;
J Clin Oncol; 2003 Jan; 21(1):54-9. PubMed ID: 12506170
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
7. Treatment implications of postoperative chemoradiotherapy for squamous cell carcinoma of the oral cavity with minor and major extranodal extension.
de Almeida JR; Truong T; Khan NM; Su JS; Irish J; Gilbert R; Goldstein D; Huang SH; O'Sullivan B; Hosni A; Hope A; Waldron J; Hansen AR; Spreafico A; Siu LL; Perez-Ordonez B; Xu W; Weinreb I
Oral Oncol; 2020 Nov; 110():104845. PubMed ID: 32615441
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001.
Watanabe K; Toi Y; Nakamura A; Chiba R; Akiyama M; Sakakibara-Konishi J; Tanaka H; Yoshimura N; Miyauchi E; Nakagawa T; Igusa R; Minemura H; Mori Y; Fujimoto K; Matsushita H; Takahashi F; Fukuhara T; Inoue A; Sugawara S; Maemondo M;
Transl Lung Cancer Res; 2021 Feb; 10(2):712-722. PubMed ID: 33718016
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
11. The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience.
Yeh TJ; Chan LP; Tsai HT; Hsu CM; Cho SF; Pan MR; Liu YC; Huang CJ; Wu CW; Du JS; Wang HC
Biology (Basel); 2021 Feb; 10(2):. PubMed ID: 33672266
[TBL] [Abstract][Full Text] [Related]
12. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K
BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755
[TBL] [Abstract][Full Text] [Related]
13. Two-year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial.
Chitapanarux I; Kittichest R; Tungkasamit T; Asakit T; Chomprasert K; Chakrabandhu S; Onchan W; Traisathit P
Curr Probl Cancer; 2021 Feb; 45(1):100620. PubMed ID: 32713518
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
16. Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
Tang QN; Liu LT; Qi B; Guo SS; Luo DH; Sun R; Sun XS; Chen DP; Guo L; Mo HY; Wang P; Liu SL; Liang YJ; Li XY; Yang ZC; Chen QY; Mai HQ; Tang LQ
JAMA Netw Open; 2021 Dec; 4(12):e2138470. PubMed ID: 34928359
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
Yin Y; Zhou Z; Li Z; Shen M; Qin Y; Yang C; Wang R; Kang M
Radiat Oncol; 2022 Jul; 17(1):135. PubMed ID: 35906636
[TBL] [Abstract][Full Text] [Related]
18. Radiologic-Pathologic Correlation of Extranodal Extension in Patients With Squamous Cell Carcinoma of the Oral Cavity: Implications for Future Editions of the TNM Classification.
Almulla A; Noel CW; Lu L; Xu W; O'Sullivan B; Goldstein DP; Hope A; Perez-Ordonez B; Weinreb I; Irish J; Gullane P; Chepeha D; Tong L; Yu E; Huang SH
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):698-708. PubMed ID: 29970315
[TBL] [Abstract][Full Text] [Related]
19. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
Chen JH; Huang WY; Ho CL; Chao TY; Lee JC
Head Neck; 2019 Nov; 41(11):3775-3782. PubMed ID: 31435974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
